
Considerations for CMC Information to Support Emergency Use Authorization of Biotechnology Products

Speaker Presentation Lynch Patrick, CDER, FDA, 2021
Considerations for CMC Information to Support Emergency Use Authorization of Biotechnology Products
Considerations for CMC Information to Support Emergency Use Authorization of Biotechnology Products